Cargando…

The utilization pattern of serum tumor markers in lung cancer patients: A population‐based retrospective descriptive study

BACKGROUND: The trends in usage of tumor markers, including CEA, SCC, NSE, Cyfra21‐1, and ProGRP, in Chinese lung cancer patients in the real‐world setting are not fully investigated. METHODS: A retrospective descriptive study was conducted using the database of Qilu Hospital of Shandong University,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Hongchun, Zhang, Jian, Li, Xiaoli, Zhang, Cheng, Zheng, Shuli, Chi, Yihong, Sheng, Xia, Zhang, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7676212/ https://www.ncbi.nlm.nih.gov/pubmed/32638440 http://dx.doi.org/10.1002/jcla.23465

Ejemplares similares

Cross-Sectional Study to Establish the Utility of Serum Tumor Markers in the Diagnosis of Lung Cancer
por: Mehta, Anurag, et al.
Publicado: (2021)

Assessment of Serum Tumor Markers for Predicting Ocular Metastasis in Lung Adenocarcinoma: A Retrospective Study
por: Shi, Wen-Qing, et al.
Publicado: (2020)

The Indicative Value of Serum Tumor Markers for Metastasis and Stage of Non-Small Cell Lung Cancer
por: Jiang, Chunyang, et al.
Publicado: (2022)

Serum GRP78 as a Tumor Marker and Its Prognostic Significance in Non-Small Cell Lung Cancers: A Retrospective Study
por: Ma, Xiao, et al.
Publicado: (2015)

Clinical Evaluation and Cost-Effectiveness Analysis of Serum Tumor Markers in Lung Cancer
por: Wang, Rong, et al.
Publicado: (2013)

The combination of folate receptor-positive circulating tumor cells and serum tumor markers suggests a histological diagnosis of lung cancer
por: Lv, Xing, et al.
Publicado: (2022)

Development of a prediction model with serum tumor markers to assess tumor metastasis in lung cancer
por: Wang, Jiasi, et al.
Publicado: (2020)

Predictive Role of Serum Tumor Markers in Diagnosis of Pulmonary Tuberculosis
por: MA, Jingjing, et al.
Publicado: (2016)

Serum pleiotrophin as a diagnostic and prognostic marker for small cell lung cancer
por: Xu, Chunhua, et al.
Publicado: (2019)

Analysis of tumor markers in pleural effusion and serum to verify the correlations between serum tumor markers and tumor size, TNM stage of lung adenocarcinoma
por: Chen, Zhongqing, et al.
Publicado: (2019)

The utility of folate receptor-positive circulating tumor cell in cancer diagnosis in the elderly population
por: Li, Na, et al.
Publicado: (2019)

Trajectories of Perioperative Serum Tumor Markers and Colorectal Cancer Outcomes: A Retrospective, Multicenter Longitudinal Cohort Study
por: Li, Chunxia, et al.
Publicado: (2021)

Correlation Between Serum Tumor Marker Levels and Connective Tissue Disease-Related Interstitial Lung Disease
por: Bao, Yunqi, et al.
Publicado: (2021)

Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers
por: Jiang, Rifeng, et al.
Publicado: (2017)

Prognostic evaluation of preoperative serum tumor marker‐negative cases in non‐small cell lung cancer: A retrospective study
por: Onuki, Yuichiro, et al.
Publicado: (2022)

Description and Utilization of Telewound Monitoring Services in Primary Care Patients with Acute Wounds in Singapore: A Retrospective Study
por: Zhu, Xiaoli, et al.
Publicado: (2022)

Serum Tumor Markers for Early Diagnosis of Primary Hepatocellular Carcinoma
por: Zong, Jingjing, et al.
Publicado: (2020)

Serum exosomal proteomics analysis of lung adenocarcinoma to discover new tumor markers
por: Liu, Shanshan, et al.
Publicado: (2022)

Genome-wide association study of serum tumor markers in Southern Chinese Han population
por: Li, Xiukuan, et al.
Publicado: (2022)

Serum biochemical markers in lung cancer.
por: Burt, R. W., et al.
Publicado: (1978)

Application of serum SELDI proteomic patterns in diagnosis of lung cancer
por: Yang, Shuan-ying, et al.
Publicado: (2005)

Prediction models of colorectal cancer prognosis incorporating perioperative longitudinal serum tumor markers: a retrospective longitudinal cohort study
por: Li, Chunxia, et al.
Publicado: (2023)

Changes in lung cancer-related serum tumor markers in patients with chronic kidney disease and determination of upper reference limit
por: Miao, Qiang, et al.
Publicado: (2022)

Serum Clusterin as a Tumor Marker and Prognostic Factor for Patients with Esophageal Cancer
por: Guo, Wei, et al.
Publicado: (2014)

Utility of Serum Ki-67 as a Marker for Malignancy in Dogs
por: Estaller, Annkathrin, et al.
Publicado: (2022)

Serum APE1 Autoantibodies: A Novel Potential Tumor Marker and Predictor of Chemotherapeutic Efficacy in Non-Small Cell Lung Cancer
por: Dai, Nan, et al.
Publicado: (2013)

Prevalence and patterns of maxillofacial trauma: a retrospective descriptive study
por: Al-Hassani, Ammar, et al.
Publicado: (2019)

The Prognostic Value of Preoperative Serum Tumor Markers in Non-Small Cell Lung Cancer Varies With Radiological Features and Histological Types
por: Chen, Haiqing, et al.
Publicado: (2021)

Metabolic phenotypes, serum tumor markers, and histopathological subtypes in predicting bone metastasis: analysis of 695 patients with lung cancer in China
por: Jiang, Maoqing, et al.
Publicado: (2023)

Predictive and prognostic value of preoperative serum tumor markers in resectable adenosqamous lung carcinoma
por: Zhi, Qiongjie, et al.
Publicado: (2016)

Serum tumor markers level and their predictive values for solid and micropapillary components in lung adenocarcinoma
por: Li, Zhihua, et al.
Publicado: (2022)

Baseline serum tumor markers predict the survival of patients with advanced non-small cell lung cancer receiving first-line immunotherapy: a multicenter retrospective study
por: Huang, Jian, et al.
Publicado: (2023)

Dynamic monitoring of serum tumor markers as prognostic factors in patients with advanced non-small-cell lung cancer treated with first-line immunotherapy: a multicenter retrospective study
por: Yang, Xiongwen, et al.
Publicado: (2023)

Serum cytokeratin 19 fragment in advanced lung cancer: could we eventually have a serum tumor marker?
por: Bastawisy, Ahmed El, et al.
Publicado: (2014)

Characterization of m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration in Ovarian Cancer
por: Luo, Yihong, et al.
Publicado: (2022)

Serum Tumor Marker Carbohydrate Antigen 125 Levels and Carotid Atherosclerosis in Patients with Coronary Artery Disease
por: Sang, Guo-Yao, et al.
Publicado: (2018)

Pattern of use of radiotherapy for lung cancer: a descriptive study
por: Tovar, Isabel, et al.
Publicado: (2014)

Predictive nomogram based on serum tumor markers and clinicopathological features for stratifying lymph node metastasis in breast cancer
por: Geng, Sheng-Kai, et al.
Publicado: (2022)

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study
por: Lang, David, et al.
Publicado: (2020)

Serum tumor markers for the prediction of concordance between genomic profiles from liquid and tissue biopsy in patients with advanced lung adenocarcinoma
por: Jiao, Xiao-Dong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8h0jjtsapu0tu7shbstal7simd